by Cort Johnson | Dec 17, 2023 | Homepage, long COVID, Putrino, Treatment
The blog – taken from presentations at PolyBio’s Fall Long COVID Symposium – is about innovation at the treatment level in long COVID. Long COVID, like chronic fatigue syndrome (ME/CFS), like fibromyalgia, etc., presents a problem – it’s...
by Patrick Usher | Dec 9, 2023 | Blood Volume, Homepage, Psychiatry, RAAS
Patrick explores whether the high levels of thirst found in ME/CFS have been misdiagnosed as psychogenic polydipsia and what to do about them.
by Cort Johnson | Dec 4, 2023 | Homepage, Mind/body, Mindfulness, Treatment
Dan Neuffer talks about what stops some people with ME/CFS and/or fibromyalgia from recovering and reports that he's seen many people who are bedbound recover or improve dramatically.
by Cort Johnson | Nov 29, 2023 | Autoimmune, B-cells, COVID-19, Epstein-Barr Virus, Homepage, Immune, long COVID, Monoclonal antibodies, Pathogens, Recovery stories, Research, T-cells
Three case reports indicate that monoclonal antibody therapy rapidly restored severely ill patients with long term cases of long COVID to health. Implications for chronic fatigue syndrome are explored.
by Cort Johnson | Nov 14, 2023 | Autophagy, Chheda, Energy Production, Homepage, Kaufman, Oxidative Stress, Peterson
Clinical trials – once a rarity for chronic fatigue syndrome (ME/CFS) – suddenly seem to be popping up all around the place. The Open Medicine Foundation just announced its first two-fer (two drugs tested together) clinical trial, Solve M.E. has funded at...
by Cort Johnson | Nov 12, 2023 | Dopamine, Drugs, Homepage, Low Dose Naltrexone, Mestinon, Neuroinflammation, Systrom, Trazodone, Treatment
The Open Medicine Foundations LIFT trial will explore the effects of two drugs - low dose naltrexone and Mestinon on chronic fatigue syndrome (ME/CFS)